Home/Innovation Pharmaceuticals/Leo Ehrlich

LE

Leo Ehrlich

Chief Executive Officer, CFO, Board Chairman

Innovation Pharmaceuticals

Therapeutic Areas

Oncology Supportive Care Inflammatory Diseases Infectious Diseases Dermatology Gastroenterology

Innovation Pharmaceuticals Pipeline

Drug	Indication	Phase
Brilacidin	Oral Mucositis (Prevention/Treatment)	Phase 3 (planned)
BEAMED	Surgical Oncology / Epilepsy	Pre-clinical

Leadership Team at Innovation Pharmaceuticals

Senior Vice President, Clinical Sciences and Portfolio Management

View full Innovation Pharmaceuticals profile